In this informative session we decode the intricate landscape of regulatory affairs outsourcing in the CEE region and provide practical, implementable strategies to optimize and maximize your operations and outsourcing strategies.
Let’s discuss how we can streamline your outsourcing strategy and make your regulatory operations in CEE more efficient.
Is medical information (MI) and pharmacovigilance (PV) integration still optional? The short answer is no. Regulators expect every enquiry, report, and safety update to connect seamlessly. When these functions work in isolation, gaps appear, and those gaps create...
In this Biomapas Insights episode, Martijn van de Leur, Chief Commercial Officer, speaks with Terry Pirovolakis, CEO of Elpida Therapeutics, the organisation that grew out of the CureSPG50 advocacy movement. Together, they explore how a parent-led mission to help...
Pharmacovigilance outsourcing has become crucial for biotech companies to remain compliant and safeguard patients. When you bring a drug to market in Europe or globally, your Qualified Person for Pharmacovigilance (QPPV) serves as your first line of defense. The right...
Discover how Biomapas provides all the support to accelerate your clinical trials and optimize your drug development process.
Reliable support for every phase of your clinical trial, from recruitment to results.
Flexible safety monitoring to keep your products compliant and trusted.
Confidently navigate regulatory challenges with expert support.
Clear, accurate medical information 24/7, tailored for global audiences.
Export auditors help identify gaps and close them with actionable solutions.
